Skip to main content

Lakefront Biotherapeutics NV

LKFT
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001421876

No open-market purchases or sales by Lakefront Biotherapeutics NV insiders were filed in the last 90 days; 76 institutions reported holding it in 13F filings for Q2 2026, worth $960.3M in total; Greenlight Capital is the only superinvestor holding it.

Other share classesGLPGF

Q4 2024 vs. Q3 2024

How the institutions holding Lakefront Biotherapeutics NV changed between Q3 2024 and Q4 2024.

All holders in Q4 2024All holders in Q3 2024

13F holders of LKFT: Q3 2024 compared with Q4 2024
MeasureQ3 2024Q4 2024Change
Holders7982+3
Shares13.7M31.1M+17.4M (+127.5%)
Value$393.4M$856.9M+$463.5M (+117.8%)

New holders (13)

Institutions that held Lakefront Biotherapeutics NV at the end of Q4 2024 but not at the end of Q3 2024.

Institutions new to LKFT in Q4 2024
InstitutionSharesValue% of portfolio
Gilead Sciences, Inc.16,707,477$461.7M29.77%
Deep Track Capital, LP780,778$21.5M0.81%
Woodline Partners LP45,899$1.26M0.01%
Aquatic Capital Management LLC26,418$726.5K0.02%
Verition Fund Management LLC17,689$486.4K0.00%
Wealthedge Investment Advisors, LLC11,301$310.8K0.14%
Jane Street Group, LLC11,137$306.3K0.00%
JustInvest LLC9,257$254.6K0.00%
R Squared Ltd930$25.6K0.02%
GF Fund Management Co. Ltd.293$8.06K0.00%
Farther Finance Advisors, LLC159$4.37K0.00%
UMA Financial Services, Inc.139$3.82K0.00%
IFP Advisors, Inc0$1100.00%

Sold out (10)

Institutions that held Lakefront Biotherapeutics NV at the end of Q3 2024 and filed for Q4 2024 without it.

Institutions that sold out of LKFT in Q4 2024
InstitutionShares, Q3 2024Value, Q3 2024
Logos Global Management LP800,000$23.0M
AlphaCentric Advisors LLC108,500$3.12M
Optiver Holding B.V.69,396$2.00M
HRT Financial LP16,241$467.0K
Headlands Technologies LLC2,742$78.9K
Deutsche Bank AG375$10.8K
Planned Solutions, Inc.100$2.88K
EverSource Wealth Advisors, LLC32$921
Jaffetilchin Investment Partners, LLC5$144
CWM, LLC8$0